Cargando…
Celastrol Enhances the Anti-Liver Cancer Activity of Sorafenib
BACKGROUND: Sorafenib, a multiple-target-point kinase inhibitor, has been used as a standard treatment for advanced liver cancer and has shown therapeutic benefits. However, resistance often occurs, prompting the need for identification of synergizing agents. Celastrol is a major active ingredient o...
Autores principales: | Zhang, Rui, Chen, Zhi, Wu, Shu-Sheng, Xu, Jun, Kong, Ling-Chun, Wei, Pei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559000/ https://www.ncbi.nlm.nih.gov/pubmed/31152143 http://dx.doi.org/10.12659/MSM.914060 |
Ejemplares similares
-
Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2
por: Wang, Guanghui, et al.
Publicado: (2019) -
Rho GTPase Activating Protein 24 (ARHGAP24) Regulates the Anti-Cancer Activity of Sorafenib Against Breast Cancer MDA-MB-231 Cells via the Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway
por: Dai, Xianping, et al.
Publicado: (2018) -
Inhibitor of Differentiation 1 (ID1) Facilitates the Efficacy of Sorafenib in Non-Small Cell Lung Cancer Cells through Suppressing Epithelial to Mesenchymal Transition
por: Zhao, Yu-xiao, et al.
Publicado: (2020) -
Transient Elastography with Serum Hepatitis B Surface Antigen Enhances Liver Fibrosis Detection
por: Dai, Tianyi, et al.
Publicado: (2016) -
Anti-Proliferative Effect of Wogonin on Ovary Cancer Cells Involves Activation of Apoptosis and Cell Cycle Arrest
por: Zhao, Qingyang, et al.
Publicado: (2019)